In addition, a small pilot safety study published in Alternative Therapies in Health and Medicine showed that intravenous infusions of BPC-157 up to 20 milligrams were well-tolerated with no reported adverse effects in healthy adults, providing initial evidence that the peptide can be administered safely, a necessary step before larger efficacy trials on healing outcomes are conducted
The result is improved wound stability, reduced scar formation, and stronger tissue remodeling, supporting its exploration in both trauma and cosmetic regenerative research
If NAD+ is already in the stack and the stall persists, check consistency before raising the dose missed days move the pool more than milligrams do
Stopping injections will lead to recurrence of deficiency, as the underlying malabsorption cannot be corrected
Product information Research applications Suitable for peptide characterisation, analytical method development, molecular interaction studies and other controlled laboratory investigations